Physician profile
Peter Sol Warshawsky
NPI 1285855726
$12,488.27
in general payments reported to CMS, 2019-2025
5 companies · $69.39 in 2025
The $69.39 reported for 2025 was less than what a typical Periodontics provider received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,019 · 2020: $111 · 2021: $58.67 · 2022: $3,360 · 2023: $6,296 · 2024: $1,575 · 2025: $69.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,075 · Consulting Fee: $1,500 · Food and Beverage: $869 · Education: $288 · Travel and Lodging: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,075.00 |
| Consulting Fee | $1,500.00 |
| Food and Beverage | $869.41 |
| Education | $287.50 |
| Travel and Lodging | $208.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $9,353.97 | 2019-2024 | Astra Tech Implant System, Implant Dentistry, Consumable Dentistry |
| Henry Schein, INC. | $2,500.00 | 2019-2023 | |
| Straumann USA LLC | $309.18 | 2020-2023 | |
| 3m Company | $202.87 | 2022 | |
| Geistlich Pharma, North America, INC. | $122.25 | 2024-2025 | Biomaterials, Geistlich Bio-Gide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Warshawsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.